News
Tempus AI’s TEM stock has surged nearly 13% since its second-quarter 2025 earnings release. The quarter saw strong top-line ...
MarketBeat on MSN5h
Tempus AI's Strong Q2 Fuels Growth Story-More Upside Ahead?
Over the past two years, one of the most interesting healthcare companies to go public is none other than Tempus AI (NASDAQ: ...
The collaboration will fund early-stage clinical development of SB-4826, CIT’s first-in-class SUMO E1 inhibitor, for patients ...
TipRanks on MSN10h
tempus AI Inc Class A call volume above normal and directionally bullish
Bullish option flow detected in tempus AI ( TEM) Inc Class A with 45,265 calls trading, 2x expected, and implied vol increasing over 1 point to 72.64%. Aug-25 70 calls and Aug-25 75 calls are the most ...
Tempus AI raises 2025 revenue outlook again after strong Q2 growth in genomics and AI-driven oncology solutions.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback